α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment

Overview of attention for article published in Molecular Neurodegeneration, April 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 18,032 followers.

RT @KantorNeurology: #pascongress: Poster on @pfizer #Bosutinib #Bosulif, another tyrosine kinase inhibitor studied in @Georgetown phase 2…

RT @KantorNeurology: #pascongress: Poster on @pfizer #Bosutinib #Bosulif, another tyrosine kinase inhibitor studied in @Georgetown phase 2…

#pascongress: Poster on @pfizer #Bosutinib #Bosulif, another tyrosine kinase inhibitor studied in @Georgetown phase 2 trial for #DLB Dementia with Lewy Bodies - safe and enters brain where it facilitates clearance of alpha-synuclein. Also read https://t.co

α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment. https://t.co/z5LPnO3qKs

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.